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ABSTRACT 
To date, the College of Radiology (CoR) does not see any clear benefit in performing whole body screening 
computed tomography (CT) examinations in healthy asymptomatic individuals. There are radiation risk issues in CT and 
principles of screening should be adhered to. There may be a role for targeted cardiac screening CT that derives calcium 
score, especially for asymptomatic medium-risk individuals and CT colonography when used as part of a strategic 
programme for colorectal cancer screening in those 50 years and older. However, population based screening CT 
examinations may become appropriate when evidence emerges regarding a clear benefit for the patient outweighing the 
associated radiation risks. © 2008 Biomedical Imaging and Intervention Journal. All rights reserved. 
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PREAMBLE 
After examining the published literature to date, the 
College of Radiology (CoR) does not see any clear 
benefit in performing whole body screening computed 
tomography (CT) examinations in healthy asymptomatic 
individuals. This recommendation is made based on 
available evidence and the points taken into 
consideration are discussed in the various sections below. 
It does not replace case-by-case or individual clinical 
assessment where the need arises. It is also not meant to 
be used for legal purposes.  
This position provides guidance for medical and 
health care professionals for appropriate radiologic care 
that is as effective and safe as possible for the patient. It 
is recognised that many factors come into play in the 
delivery of health care. This includes the patient's 
condition, available resources and new information, 
results from studies, as well as new technologies. 
All parties, i.e. the radiologist who agrees to 
perform and interpret this examination, the physician 
prescribing the examination (if the patient is not self-
referred) as well as the patient, must fully understand the 
limitations and implications of the findings, as well as 
the risks entailed (from the radiation and contrast media). 
All must be cognisant of the fact that there may be 
ensuing investigations for abnormalities found on the CT 
scan and these may have potentially profound financial, 
psychological and physical effects.  
INTRODUCTION 
Sectional imaging such as Computed Tomography 
(CT) or Magnetic Resonance Imaging (MRI) have 
revolutionised the capabilities for medical imaging 
studies, image-guided therapeutic intervention, and 
improved targeted radiation therapy. Unlike non-ionising 
ultrasound examinations, it is not limited by gas and 
body habitus or conventional radiographic imaging 
where there is overlapping of significant volumes of 
tissue. CT provides visualisation of body structures 
previously not well visualised except through open 
surgery. CT is much more widely available and therefore 
much more utilised than MRI. CT has benefited many 
patients by clinching the diagnosis, guiding surgery, 
staging a disease much more accurately and allowing 
radiation therapy to proceed ever more precisely. 
The varieties of CT scanners currently in clinical use 
range from single slice to spiral, multislice and dual 
source technology as well as electron beam CT (EBCT). 
Scans can now proceed more rapidly by acquiring each 
sectional image of the body in subsecond or millisecond 
acquisition times. Multislice, dual source and EBCT 
allow elegant multiplanar and 3-D reconstructions as 
well. Virtual colonoscopy is one good example where 
post processing 3-D rendering has been invaluable. 
Therefore, it is not surprising that CT is now being 
explored and employed in whole body screening for 
disease. In fact, screening CT centres have sprouted up 
based on the premise of wellness screening – to detect 
diseases before they become more advanced. A whole 
body CT is being marketed directly to consumers 
(patients), and they, in turn, are now demanding for the 
test. 
DOES WHOLE BODY SCREENING CT SATISFY THE 
CRITERIA OF A GOOD SCREENING TEST? 
The following are intended as points of 
consideration rather than questions. All focus on whether 
whole body screening CT meets the standards of a good 
screening test for the target diseases (diseases generally 
being marketed for are cancer and coronary artery 
disease) [1,2,3]. Do note that whole body screening CT 
may include the head, neck, thorax, abdomen and pelvis. 
In some centres or countries, this may only include the 
neck, thorax, abdomen and pelvis, or just the thorax, 
abdomen and pelvis. 
1.  Results from large-scale randomised clinical 
trials (RCT) for evaluation of whole body 
screening in apparently healthy individuals has 
not been published to date. These studies may 
be difficult to perform because of ethical issues 
regarding radiation dose, being very significant 
in whole body CT as well as the costs of the 
examination and the risks from contrast media, 
if administered in routine whole body screening 
CT. In addition, RCTs generally tend to be 
disease-specific, and interpreting results of 
trials where an individual is being screened for 
multiple diseases at the same time may not be 
straightforward. In addition, CT technology is 
rapidly advancing and therefore by the time an 
RCT is concluded, would the results be 
applicable? 
2.  Indices for whole body CT such as negative 
predictive rate, sensitivity, specificity, false 
negative, false positive and others are unknown. 
Therefore the cost-effectiveness or more 
comprehensively, the benefit-risk-cost 
evaluation is lacking. 
3.  Malpractice issues have to be considered in 
screening CT such as would arise if there was a 
missed diagnosis and/or where intravenous 
contrast media used resulted in a severe 
contrast reaction. Linked to the possibility of 
missed diagnosis, is the question of whether 
intravenous contrast media should be routinely 
used for whole body screening CT 
examinations. It is known that non-enhanced 
CT of the abdomen is generally inadequate for 
lesion characterisation. [4] 
4.  No specific guidelines exist for follow-up or 
further evaluation when abnormalities are 
detected for general whole body screening. 
Currently there are some guidelines or 
consensus statements for lung CT but this is 
because there is a basis for the size or other 
pretest probabilities. Guidelines for lung CT Available online at http://www.biij.org/2008/4/e44 
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(relatively organ specific) are easier to establish 
than for abdomen CT (multiple organs). 
PRINCIPLES IN SCREENING  
Screening involves a test, procedure or investigation 
that is used to identify a condition of disease before it 
manifests with signs and symptoms. It is based on the 
premise that detecting a disease at its earliest affords the 
best chance of cure.  
A screening test is considered effective if it 
produces a statistically significant reduction in disease 
mortality. Screening tests can be applied to the whole 
population or to a subset of the population, for example, 
that is based on the risk profile of the person for a 
specific disease.  
Main considerations for screening are as follows [3]: 
1.  Does the disease merit screening? (For example, 
is the disease very common in the population in 
question and is proving to be a major healthcare 
burden to treat and care for?) 
2.  Is there a reliable screening test for the disease 
in question? The false positive and false 
negative rates, positive and negative predictive 
values as well as accuracy are important 
parameters. 
3.  Is effective intervention/treatment available for 
the disease in question, if detected early? There 
is no point in screening for a disease if there is 
no cure or effective treatment for the disease. 
There is also no point in treating a disease that 
is slowly progressing such that treating it early 
may not make a difference to the patient’s 
lifespan. 
4.  Therefore, screening in general requires the 
careful consideration of a number of factors 
including a careful cost-benefit analysis. 
Individuals opting for any screening 
examination should be counseled as to the 
benefits and risks associated with the 
examination. 
RADIATION ISSUES IN CT  
The effective doses from diagnostic CT procedures 
are typically estimated to be in the range of 1 to 10 mSv. 
However, for a whole body CT, the effective dose for CT 
head, thorax, abdomen and pelvis is easily 20 mSv [5]. A 
CT examination with an effective dose of 10 mSv may 
be associated with an increase in the chance of fatal 
cancer of approximately 1 in 2000. Therefore, a CT scan 
must only be performed when the benefits outweigh the 
risks, and when information from the CT scan will 
positively affect the management of the patient’s 
condition. 
The amount of radiation dose received by the patient 
is variable by a factor of 10 [6, 7], depending on the size 
of the patient, make and type of CT scanner, scanning 
parameters and body part being scanned. It is also an 
established fact that CT studies account for the largest 
population radiation dose from medical diagnostic 
studies and this is increasing rapidly with time [8,9,10]. 
In 1998, CT contributed 42% of the average effective 
dose per capita from diagnostic exposures in the 
Netherlands [8].  
According to the UNSCEAR 2000 Report on 
Sources and Effects of Ionising Radiation, the percentage 
contribution by CT scans to global collective dose from 
medical x-ray examinations have increased from about 
14% between 1955 and 1990 to about 33% between 1991 
and 1996 [9]. The growth is phenomenal and, therefore, 
the collective dose to the population from medical 
sources of ionising radiation is significant. 
THE COLLEGE OF RADIOLOGY, ACADEMY OF MEDICINE 
POSITION ON WHOLE BODY SCREENING CT SCANS 
After examining the published literature to date, the 
College of Radiology (CoR) does not see any clear 
benefit in performing whole body screening computed 
tomography (CT) examinations in healthy asymptomatic 
individuals. Indiscriminate whole body screening CT 
does not satisfy the criteria needed for a good screening 
test. There is also no standardisation of what constitutes 
a whole body CT scan and whether contrast media 
should be used. There is no evidence-based consensus of 
the various diseases for which morbidity and mortality 
are allegedly reduced. It should be noted that there is no 
“one size fits all” for a properly conducted CT scan, 
especially so if the whole body is involved. In addition, a 
CT scan examination is costly when it involves many 
sections of the body (as in whole body) and contrast 
media is used with attendant risks.  
The false positives from the whole body screening 
CT will lead to additional tests, some of which may be 
high risk (for example fatality from biopsy procedures); 
and uncertainty from findings of unknown clinical 
significance will lead to unnecessary investigations and 
anxiety for the patient. All these translate to financial and 
psychological burden to the patient, as well as financial 
and other burdens to the healthcare system. Finally as 
discussed above, the risks from radiation are real and 
significant.  
Theoretically, the perceived benefits are earlier 
detection leading to earlier intervention, reduction of 
morbidity and mortality for the patient, and lower overall 
health costs and burden to the healthcare infrastructure. 
However, these benefits have not been proven yet. 
Therefore, the risks outweigh the benefits in whole body 
screening CT at this time. 
Every medical procedure must have indications and 
justification for its use. Consideration must be given to 
the available resources versus clinically useful 
information that alters management inclusive of financial 
and safety issues. This is even more imperative with 
medical procedures requiring the administration of 
ionising radiation. 
Justification, optimisation and dose limitation 
remain the main tenets for radiology practitioners. In Available online at http://www.biij.org/2008/4/e44 
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clinical scenarios where benefit exceeds risks and further 
management of the patient is dependent on information 
gleaned from the CT scan, the examination is deemed 
justified. The radiologist and the radiographer/radiologic 
technologist operating the CT scanner must optimise the 
examination to get the most information by using scan 
parameters that do not use excessive radiation (dose 
limitation). CT scans should be performed keeping in 
mind the principle of ALARA (As Low As Reasonably 
Achievable).  
In Malaysia, all CT scans must be conducted by a 
trained medical practitioner who is a qualified radiologist 
with a valid practicing licence from the Malaysian 
Medical Council (MMC) and is preferably listed in the 
National Specialist Register (currently a voluntary 
registration process). The equipment must be operated by 
trained and qualified radiographers. The facility 
providing the CT service must have in place radiation 
protection and quality assurance programmes.  
SPECIAL CIRCUMSTANCES FOR TARGETED SCREENING 
CT PROCEDURES 
This position statement would be incomplete 
without also discussing some of the results of studies 
done for screening CT confined to specific areas of the 
body, as well as for diseases which are deemed common 
and for which earlier intervention may impact positively 
on morbidity and mortality. 
A. CT Heart for Calcium Score 
Calcium scoring in cardiac CT is deemed 
appropriate for patients at medium risk for coronary 
artery disease, as the information from the calcium score 
may render the patient as high risk, requiring more 
intensive risk modification [11]. More recently, calcium 
scoring may prove to be independently predictive of 
cardiovascular risk and adds incremental prognostic 
information to the conventional risk factor scoring 
methods [11]. 
B. CT colonography (Other names are virtual 
colonoscopy and virtual colonography) 
This is a CT examination of the colon, and typically 
involves distending the colon with carbon dioxide or air, 
and then performing a CT scan of the abdomen and 
pelvis, usually in both prone and supine positions. The 
data is reconstructed and can provide axial images, 3-D, 
MPR images as well as colon fly-through video images. 
The radiation dose in CT colonography ranges from 
1.8  mSv to 15  mSv with an average of 8  mSv. The 
radiation dose in barium enema (barium study using 
x-ray fluoroscopy) is typically 7 mSv. 
Recently, CT colonography was recognised as a 
screening tool in the Joint Guideline of the American 
Cancer Society, the US Multi-Society Task Force on 
Colorectal Cancer and the American College of 
Radiology on Screening and Surveillance for the Early 
Detection of Colorectal Cancer and Adenomatous Polyps, 
2008 [12, 13]. Screening average-risk individuals over 
50 years old may reduce mortality from colorectal cancer 
[13]. Screening should proceed in a proper programme 
that begins with risk stratification, and based on the 
findings, the results from the initial test should be 
followed through appropriately. For this screening 
examination to be effective, the patient must adhere to 
the programme and undergo good quality tests. CT 
colonography must be used judiciously and existing 
recommendations for screening in low, medium and high 
risk individuals should be factored into the decision to 
proceed with screening CT colonography. 
C. Screening lung CT is still controversial [14, 15, 16, 
17, 18].  
Although CT is probably best at detecting early lung 
cancer, the evidence to suggest that treatment / 
intervention at this stage reduces mortality or improves 
life span is not conclusive [19]. In addition, lung CT 
detects many small benign nodules, and the cost-safety-
benefit analysis is not straightforward, as lung biopsy 
carries significant risks. There are ongoing trials in 
screening lung CT in the at-risk population, including the 
National Lung Screening Trial in the USA [20]. 
However, even trials are surrounded by controversy. The 
International Early Lung Cancer Action Programme was 
recently reported to have received some funding from a 
tobacco company [21]. The latter adds to the other 
questions on lead time bias, study length and over 
diagnosis bias. 
CONCLUSION 
After an extensive review of the published literature, 
the CoR at this time does not recommend whole body 
screening CT scans in healthy asymptomatic individuals, 
as the risks (safety, psychological, cost) outweigh the 
potential benefits (reduced mortality, burden and costs to 
healthcare systems). The appropriateness of screening 
CT examinations may change with new evidence, 
improvements or changes in CT technology, disease 
pattern, type, treatment, and various other factors. 
[12-28]. 
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